<PAGE>
                    U.S. SECURITIES AND EXCHANGE COMMISSION
                             Washington, D.C. 20549

                                   FORM 10-QSB/A

(Mark One)
[x] QUARTERLY REPORT UNDER SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT
OF 1934
                 For the quarterly period ended March 31, 2005

[ ] TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE EXCHANGE ACT

     For the transition period from ___________ to ___________

                       Commission file number: 000-29087

                                Datascension, Inc.
                  --------------------------------------------
                 (Name of small business issuer in its charter)

        Nevada                                               87-0374623
------------------------                                   --------------
(State or other jurisdiction of                            (IRS Employer
incorporation or organization)                            Identification No.)

145 S. State College Blvd, Suite 350, Brea, CA                 92821
-----------------------------------------------              ---------
    (Address of principal executive offices)                 (Zip Code)

                    714-482-9750 (Telephone)  714-482-9751 (Fax)
                    --------------------------------------------
                           (Issuer's telephone number)

                 6330 McLeod Drive, Suite 1, Las Vegas, NV 89120
          ----------------------------------------------------------------
(Former name, former address and former fiscal year, if changed since last
report)

      Check  whether  the  issuer (1) filed all reports required to be filed by
Section 13 or 15(d) of the Exchange  Act during the past 12 months (or for such
shorter period that the registrant was  required to file such reports), and (2)
has been subject to such filing requirements for the past 90 days. Yes [X] No [
]

               APPLICABLE ONLY TO ISSUERS INVOLVED IN BANKRUPTCY
                    PROCEEDING DURING THE PRECEDING FIVE YEARS

Check whether the Registrant filed all documents and reports required to be
filed by Section 12, 13 or 15(d) of the Exchange Act after the distribution of
securities under a plan confirmed by a court.
                                                              Yes [ ] No [ ]

                   APPLICABLE ONLY TO CORPORATE ISSUERS

The Registrant has 17,232,290 outstanding, par value $.001 per share as of
February 9, 2006.  The Registrant has 505,900 shares of Preferred Stock Series
B issued and outstanding as of February 9, 2006.

Transitional Small Business Disclosure Format (check one): Yes [ ] No [X]



                                       2
<PAGE>

                               TABLE OF CONTENTS

                                                                      Page No.

PART I.  FINANCIAL INFORMATION

Item 1.   Financial Statements......................................     4
          Balance Sheet (unaudited).................................     F1
          Statements of Operations (unaudited)......................     F2
          Statements of Cash Flows (unaudited)......................     F3
          Notes to Financial Statements.............................  F4-F7

Item 2.  Management's Discussion and Analysis of Plan
           of Operation.............................................     5

Item 3. Controls and Procedures.....................................     8


PART II. OTHER INFORMATION

Item 1.   Legal Proceedings.........................................     8

Item 2.   Unregistered Sales of Equity and Use of Proceeds..........     8

Item 3.   Defaults upon Senior Securities...........................    10

Item 4.   Submission of Matters to a Vote of Security Holders.......    10

Item 5.   Other Information..........................................   10

Item 6.   Exhibits and Reports on Form 8-K...........................   10

Signatures...........................................................   11


























                                       3

<PAGE>

                            PART I. FINANCIAL INFORMATION

Item 1. Financial Statements.

      The  condensed  financial  statements  of  Datascension,  Inc.,  ("DSEN")
included herein have been prepared  in  accordance  with  the  instructions  to
quarterly  reports  on Form 10-QSB pursuant to the rules and regulations of the
Securities and Exchange  Commission.   Certain  information  and  footnote data
necessary for fair presentation of financial position and results of operations
in  conformity  with  accounting  principles  generally accepted in the  United
States of America have been condensed or omitted.  It  is  therefore  suggested
that  these  financial  statements  be read in conjunction with the summary  of
significant accounting policies and notes  to  financial statements included in
DSEN's Annual Report on Form 10-KSB for the year ended December 31, 2004.

      In the opinion of management, all adjustments  necessary in order to make
the financial position, results of operations and changes in financial position
at March 31, 2005, and for all periods presented not misleading have been made.
The  results  of  operations  for  the  period  ended March 31,  2005  are  not
necessarily an indication of operating results to be expected for the full year
ending December 31, 2005.





                                       4

<PAGE>

			            DATASCENSION, INC.
				CONSOLIDATED BALANCE SHEETS


<TABLE>
<CAPTION>

<S>                                                        <C>           <C>
ASSETS
							      Unaudited     Audited
							       Restated	    Restated
                                                                3/31/05     12/31/04
   Current Assets:
Cash                                                            223,846      556,593
Accounts receivable                                           1,536,806    1,533,969
Prepaid expenses                                                164,829      183,306
Investment in Century Innovations                               108,469      108,469
							     ----------   ----------
   Total current assets                                       2,033,950    2,385,337

Property and Equipment, net of accumulated
   depreciation                                                 961,120      681,346

   Other Assets:
Asset held for sale (see notes)                                       -    1,015,014
Website assets, net of amortization                               4,520        4,520
Deposits                                                         21,649       25,399
Goodwill                                                      1,692,782    1,692,782
							     ----------   ----------
   Total other assets                                         1,718,951    2,737,715
							     ----------   ----------
Total Assets                                                  4,714,021    5,804,398
							     ==========   ==========

		LIABILITIES AND STOCKHOLDERS' EQUITY

                                                                3/31/05     12/31/04
   Current Liabilities:
Accounts payable                                                133,158      135,533
Accrued expenses                                              1,081,290    1,390,880
Notes payable, related party                                     52,704       60,038
Short term notes payable                                        111,417      121,742
Convertible debt,                        			499,404      241,111
Derivative liability					      1,603,282    2,408,178
Warrant Liability						912,975    1,785,877
Current portion of long-term notes payable                      105,264      116,207
							     ----------   ----------
   Total current liabilities                                  4,499,494    6,259,566

  Long-Term Debt

Long-term notes payable, net of current portion                 260,700      103,548
							     ----------   ----------
  Total long-term debt                                          260,700      103,548
							     ----------   ----------
  Total Liabilities                                           4,760,194    6,363,114


   Stockholders' Equity:
  Common stock:
Common stock, $0.001 par value, 200,000,000
shares authorized; 17,207,290 shares issued,
17,111,457 outstanding at March 31, 2005                        160,825      159,875
  Additional paid-in capital-common stock                    11,503,345   11,029,295
   Preferred stock Series B:
Preferred stock, $0.001 par value, 10,000,000
shares authorized; 508,500 Series B shares
issued and outstanding at March 31, 2005                            506          506
  Additional paid-in capital-preferred Series B                 481,994      481,994
  Subscriptions receivable                                    (480,000)    (119,063)
  Treasury stock, at cost; 95,833 shares at March 31, 2005    (134,388)    (134,388)
  Accumulated deficit                                      (11,578,455) (11,976,936)
							     ----------   ----------
Total stockholders' equity                                    (46,173)     (558,716)
							     ----------   ----------
Total Liabilities and Stockholders' Equity                    4,714,021    5,804,398
							     ==========   ==========
</TABLE>

		  See accompanying notes to the financial statements

					F-1

<PAGE>

				    DATASCENSION, INC.
			   CONSOLIDATED STATEMENT OF OPERATIONS

<TABLE>
<CAPTION>

<S>                                                 <C>             <C>
						  Unaudited	  Unaudited
						   Restated
                                                   For the         For the
                                                3 months ended  3 months ended
                                                     3/31/05       3/31/04

Revenue                                            2,005,612     2,034,455

Cost of Goods Sold                                 1,599,936     1,702,318
						  -----------   -----------
Gross Profit                                         405,676       332,137

Expenses:
Selling, general and administrative                  480,196       178,236
Depreciation                                          41,266        84,841
						  -----------   -----------
Total expenses                                       521,462       263,077

Operating Income                                   (115,786)        69,060

Other Income (Expense):
Interest income                                          220           343
Forgiveness of debt                                    2,962             -
Other income                                               -         2,185
Interest expense                                    (74,115)      (30,019)
Other Income (Expense) related to convertible      1,744,131             -
Interest income (expense) related to convertible    (155,101)            -
						  -----------   -----------
Total other income                                 1,518,097      (27,491)

Net Income (loss)                                  1,402,311       41,569

Basic weighted average number
of common shares outstanding                      16,267,846   152,364,569

Diluted weighted average number
of common shares outstanding                      16,267,846   152,364,569

Basic Net Income Per Share                              0.09          0.00

Diluted Net Income Per Share                            0.09          0.00
</TABLE>

		  See accompanying notes to the financial statements

					F-2
<PAGE>

				    DATASCENSION, INC.
			   CONSOLIDATED STATEMENT OF CASH FLOWS

<TABLE>
<CAPTION>
<S>                                                   <C>              <C>
                                                                  For the
							     3 months   3 months
                                                               ended      ended
					                      3/31/05     3/31/04
							     Unaudited   Unaudited
							      Restated
Cash Flows From Operating Activities:
Net income                                                  1,402,311    41,569
Adjustments to reconcile net income to net
cash provided by operating activities:
    Issued for services                                             -     6,250
    Noncash expenses associated with convertible debt               -         -
Change in warrant liability                                 (872,902)
Change in derivative liability			            (804,896)         -
Depreciation and amortization                                  41,266    84,840
    (Decrease) in asset held for sale                       1,015,014         -
Distribution of asset held for sale                        (1,003,831)        -
(Increase) Decrease in accounts receivable                    (2,837) (260,507)
Increase in inventory                                               -     1,304
Increase in prepaid expenses                                   60,514    56,612
Increase in deposits                                            3,750    23,492
Decrease in accounts payable                                  (2,375)  (18,634)
Decrease in accrued expenses                                (309,590)    37,929
							    ---------  --------
Net cash used by operating activities                       (473,576)  (27,145)

Cash Flows From Investing Activities:
(Increase) Decrease in notes receivable                             -   115,675
Purchase of property and equipment                          (360,077)         -
							    ---------  --------
Net cash used by investing activities                       (360,077)   115,675

Cash Flows From Financing Activities:
Increase in notes payable                                     135,884 (194,454)
Increase (Decrease) in related party payable                  (7,334)    10,661
Increase (Decrease) in convertible debt                       258,293         -
Change in stock subscriptions                                 114,063         -
Sale of common stock                                                -    75,000
(Decrease) Increase in line of credit                               -   (3,798)
							    ---------  --------
Net cash provided by financing activities                     500,906  (112,591)
							    ---------  --------

Net Increase in Cash                                        (332,747)  (24,061)

Balance, Beginning                                            556,593   122,891

Balance, Ending                                               223,846    98,830


Interest Paid                                                 181,763    33,672
Taxes Paid                                                          -         -

</TABLE>

		  See accompanying notes to the financial statements

					F-3

<PAGE>
                              DATASCENSION, INC.
                  NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

Note 1 - HISTORY AND ORGANIZATION OF THE COMPANY

Datascension, Inc.  (formerly  known as Nutek, Inc.) was incorporated in August
1991 under the laws of the State  of  Nevada as Nutek, Inc. (the "Company") and
is engaged in the market research industry.

Datascension International, Inc. and related assets were purchased on September
27,  2001  for  $2,200,000  using  company  shares   at   fair   market  value.
Datascension   International,   Inc.   is  a  premier  data  solutions  company
representing  a unique expertise in the collecting,  storage,  processing,  and
interpretation of data.  During 2002, Datascension International, Inc. expanded
operations into Costa Rica.

NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

Basis of Accounting
The Company's policy  is  to  prepare  the  financial statements on the accrual
basis of accounting.  The fiscal year end is December 31.

Cash and Cash Equivalents
Cash and cash equivalents consist of highly liquid  investments with maturities
of three months or less when purchased.

Consolidation Policy
The  accompanying  consolidated  financial  statements include the accounts  of
Datascension, Inc. and Datascension International, Inc.  All significant inter-
company balances and transactions have been eliminated.

Use of Estimates
The preparation of financial statements in conformity  with  generally accepted
accounting principles requires that management make estimates  and  assumptions
which affect the reported amounts of assets and liabilities as of the  date  of
the  financial  statements  and  revenues and expenses for the period reported.
Actual results may differ from these estimates.

Net Income Per Share

Basic  net  income  per  share is computed using the weighted average number of
shares of common stock outstanding  for  the period end.  The net income (loss)
for  the  period  end  is  divided by the weighted  average  number  of  shares
outstanding for that period to arrive at net income per share.

Diluted net income per share  reflects  the potential dilution that could occur
if the securities or other contracts to issue  common  stock  were exercised or
converted into common stock.

					F-4
<PAGE>


Convertible Debt Financing and Derivative Liabilities

In accordance with  Statement  of Financial Accounting Standards No.
133, "Accounting for Derivative Instruments and Hedging Activities,"
as amended ("SFAS 133"), the holder's  conversion  right  provision,
interest rate adjustment provision, liquidated damages clause,  cash
premium  option,  and  the redemption option (collectively, the debt
features) contained in the terms governing the Notes are not clearly
and  closely  related  to  the   characteristics   of   the   Notes.
Accordingly,   the   features   qualified   as  embedded  derivative
instruments at issuance and, because they do  not  qualify  for  any
scope  exception  within SFAS 133, they were required by SFAS 133 to
be accounted for separately from the debt instrument and recorded as
derivative financial instruments.

During the year ended  December  31,  2004,  we  recorded  an  other
expense  item  of  $2,489,116,  of  which,  $1,639,953 (expense) and
$849,163  (expense)  related  to  the  debt features  and  warrants,
respectively, to reflect the change in fair  value of the derivative
liability. During the year ended December 31,  2003,  there  was  no
income  or  expense  items  related to convertible debt as there was
none outstanding.

During  the  three  months  ended  March  31,  2005, we  recorded an
other  income item  of $1,744,131, of  which, $814,444 (income)  and
$929,687  (income)  related  to  the  debt  features  and  warrants,
respectively, to reflect the change in fair value  of the derivative
liability.  During the three  months  ended  March 31,  2004,  there
was no income  or expense items related to convertible debt as there
was none outstanding.

At each balance  sheet  date,  we  adjust  the  derivative financial
instruments   to   their  estimated  fair  value  and  analyze   the
instruments to determine  their  classification  as  a  liability or
equity.  As  of December 31, 2004, the estimated fair value  of  our
derivative liability  was  $2.41  million,  as  well  as  a  warrant
liability  of  $1.79 million. As of December 31, 2003, there was  no
asset or liability  related  to convertible debt. The estimated fair
value  of the debt features was  determined  using  the  probability
weighted  averaged  expected  cash  flows / Lattice Model. The model
uses   several   assumptions  including:  historical   stock   price
volatility (utilizing  a rolling 120 day period), risk-free interest
rate (3.50%), remaining  maturity,  and  the  closing  price  of the
Company's  common  stock  to  determine  estimated fair value of the
derivative asset. In valuing the debt features at December 31, 2004,
the company used the closing price of $0.65  and  the exercise price
of $0.30. For the year ended December 31, 2004, due  in  part  to an
increase  in the market value of the Company's common stock to $0.65
from $0.40 at issuance, the Company recorded an "other expense" item
on the consolidated  statement  of operations for the change in fair
value of $1,639,953. At December  31, 2004, the estimated fair value
of  the debt features was approximately  $2,408,178.  For  the three
months  ended   March   31,  2005,  the  estimated   value   of  the
company's debt  features  decreased to  $1,603,282, thus the company
recorded  an  "other income" item on the consolidated  statement  of
operations for  the  change  in  fair  value of the debt features of
$1,744,131 for the three months ended March 31, 2005.



Recently Issued Accounting Pronouncements

In   November 2004, the   FASB   issued   SFAS   No. 151, "Inventory   Costs an
amendment of  ARB No. 43, Chapter 4."  This Statement clarifies the  accounting
for abnormal amounts  of  idle  facility  expense, freight, handling costs, and
wasted materials.    This Statement   is   effective    for   inventory   costs
incurred during fiscal  years beginning after June 15, 2005.   Management  does
not believe this pronouncement  will  have  a  material effect on the financial
statements of the company.

In December 2004, the FASB issued SFAS No. 152,  "Accounting  for  Real  Estate
Time-Sharing  Transactions  -  an  amendment of FASB Statements No. 66 and 67."
This Statement  references the financial  accounting and reporting guidance for
real   estate   time-sharing   transactions    that  is   provided   in   AICPA
Statement   of  Position  04-2,  "Accounting  for  Real   Estate   Time-Sharing
Transactions."   This  Statement  also  states that the guidance for incidental
operations and costs incurred to sell real  estate  projects  does not apply to
real  estate  time-sharing  transactions.   This  Statement  is  effective  for
financial statements for fiscal years beginning after June 15, 2005. Management
does  not  believe  this  pronouncement  will  have  a  material effect on  the
financial statements of the company.

In  December  2004, the  FASB  issued SFAS No. 153, "Exchanges  of  Nonmonetary
Assets - an amendment of APB Opinion  No.  29."  This  Statement eliminates the
exception   for   nonmonetary  exchanges  of  similar  productive   assets  and
replaces it with a  general   exception  for  exchanges of  nonmonetary  assets
that   do    not    have  commercial   substance.    A nonmonetary exchange has
commercial substance  if  the  future  cash flows of the entity are expected to
change significantly as a result of the exchange.   This Statement is effective
for onmonetary asset exchanges occurring in fiscal periods beginning after June
15, 2005. The Company does not expect application of  SFAS  No.  153  to have a
material affect on its financial statements.

Accounts Receivable
Accounts receivable are stated at the amount management expects to collect from
outstanding  balances.   Management provides for probable uncollectible amounts
through a charge to earnings and a credit to a valuation allowance based on its
assessment of the current  status of individual accounts.  Balances outstanding
after management has used reasonable collection efforts are written off through
a charge to the valuation allowance  and a credit to trade accounts receivable.
Changes in the valuation allowance have  not  been  material  to  the financial
statements.


NOTE 3 - PROPERTY AND EQUIPMENT

  Property and equipment are made up of the following as of March 31, 2005:

           Equipment and machinery     $     472,500
           Office equipment                  943,096
           Leasehold improvements              9,959
           Accumulated depreciation         (464,435)
					-------------
                                       $     961,120

NOTE 4 - NOTES PAYABLE


NOTES PAYABLE - $1,875,000, NOVEMBER 2004

In November 2004, the Company issued $1,875,000  in principal amount
of Notes to third parties. As part of the financing transaction, the
Company issued warrants to purchase 3,125,000 shares of common stock
at a per share purchase price of $0.30 per share.

The  Notes accrue interest at a rate of prime + 3%  per  annum.  The
Notes are due and payable in November 2007.  After a thorough review
of the  terms  of the note and respective covenants, the company has
determined the more conservative method of including the entire debt
as a current liability  on  the balance sheet.  The convertible note
and  warrant documents were filed  in  an  8-K  by  the  Company  on
November  23,  2004. The Note was entered into pursuant to the terms
of a subscription  agreement  between  the  Company  and the Holder,
which was also included in the 8-K filed on November 23, 2004.

Interest  payable  on  this  Note  shall accrue at the "prime  rate"
published in The Wall Street Journal  from  time to time, plus three
percent  (3%).   The  Interest  Rate shall not be  less  than  eight
percent (8%).  Interest shall be  calculated  on  a  360  day  year.
Interest   on   the  Principal  Amount  shall  be  payable  monthly,
commencing 120 days  from  the  closing and on the first day of each
consecutive calendar month thereafter (each, a "Repayment Date") and
on the Maturity Date.

Amortizing payments of the outstanding Principal Amount of this Note
shall commence on the first (1st)  Repayment Date and shall recur on
each succeeding Repayment Date thereafter until the Principal Amount
has been repaid in full.  On each Repayment Date, the Company should
make  payments  to the Holder in the amount  of  one-  thirty-second
(1/32nd) of the initial  Principal  Amount  (the  "Monthly Principal
Amount"), together with any accrued and unpaid interest plus any and
all other amounts which are then owing under this Note that have not
been paid (the Monthly Principal Amount, together with  such accrued
and  unpaid  interest  and  such  other  amounts, collectively,  the
"Monthly Amount"). Any Principal Amount that  remains outstanding on
the Maturity Date shall be due and payable upon maturity.

Following the occurrence and during the continuance  of  an Event of
Default (as discussed in the Note), the annual interest rate  on the
Note  shall automatically be increased by two percent (2%) per month
until such Event of Default is cured.

The Holder  shall  convert  into  shares  of Common Stock all at the
Fixed Conversion Price or the maximum portion  of the Monthly Amount
due on each Repayment Date provided that the average  closing  price
of  the  Common  Stock  for the twenty (20) consecutive trading days
immediately preceding such  Repayment  Date shall be greater than or
equal  to  15%  above  the  Fixed  Conversion   Price   ("Conversion
Criterion"). The Monthly Amount due on a Repayment Date that  is not
converted  shall  be paid by the Company (i) in cash at the rate  of
104% of such Monthly  Amount  otherwise  due, or (ii) in registered,
unlegended, free- trading Common Stock at an applied conversion rate
equal to eighty-five percent (85%) of the  average  of  the five (5)
lowest  closing  bid  prices  for  the preceding twenty (20) trading
days.

The Notes also provide for liquidated  damages  on the occurrence of
several events.

As  compensation to the Subscriber, the Company agrees  to  pay  (as
liquidated damages and not as a penalty) $100 per business day after
the Delivery  Date  for  each $10,000 of Note principal amount being
converted  of  the  corresponding   Shares   which  are  not  timely
delivered.

An  additional  liquidating  damages provision states  that  if  the
Company fails to deliver to the Subscriber such shares issuable upon
conversion of a Note by the Delivery  Date and if seven (7) business
days  after  the Delivery Date the Subscriber  purchases  shares  of
Common Stock to deliver in satisfaction of a sale by such Subscriber
of the Common  Stock  which  the  Subscriber was entitled to receive
upon such conversion (a "BUY-IN"),  then  the  Company  shall pay in
cash to the Subscriber (in addition to any remedies available  to or
elected  by the Subscriber) the amount by which (A) the Subscriber's
total purchase  price  for  the  shares of Common Stock so purchased
exceeds (B) the aggregate principal  and/or  interest  amount of the
Note for which such conversion was not timely honored, together with
interest  thereon  at  a rate of 15% per annum, accruing until  such
amount and any accrued interest  thereon  is  paid  in  full  (which
amount  shall  be  paid as liquidated damages and not as a penalty).
For example, if the  Subscriber  purchases  shares  of  Common Stock
having  a  total  purchase  price of $11,000 to cover a Buy-In  with
respect to an attempted conversion  of  $10,000  of  note  principal
and/or interest, the Company shall be required to pay the Subscriber
$1,000,  plus  interest.  The  Subscriber  shall provide the Company
written notice indicating the amounts payable  to  the Subscriber in
respect of the Buy-In.

Additionally, if the Company is unable to deliver to  the  holder of
Registrable Securities, then as Liquidated Damages, an amount  equal
to  two  percent  (2%)  for  each  thirty (30) days or part thereof,
thereafter of the Purchase Price of  the Notes remaining unconverted
and purchase price of Shares issued upon  conversion  of  the Notes.
The  Company  must  pay  the Liquidated Damages in cash or an amount
equal to two hundred percent of such cash Liquidated Damages if paid
in additional shares of registered unlegended free-trading shares of
Common Stock. Such Common Stock shall be valued at a per share value
equal to 85% of the average  of  the  five  (5)  lowest  closing bid
prices  of  the  Common  Stock  for  the  twenty  (20)  trading days
preceding  the  first day of each thirty (30) day or shorter  period
for which Liquidated Damages are payable.  As of September 30, 2005,
no liquidating damages have been incurred by the company.

Redemption Option  -  The  Company will have the option of prepaying
the outstanding Principal Amount  ("Optional  Redemption"), in whole
or  in  part, by paying to the Holder a sum of money  equal  to  one
hundred  twenty  percent  (120%)  of  the  Principal  Amount  to  be
redeemed, together with accrued but unpaid interest thereon

Debt features.  The  Holder  shall  have  the  right,  but  not  the
obligation,  to  convert  all  or  any portion of the then aggregate
outstanding Principal Amount of this  Note,  together  with interest
and fees due hereon, into shares of Common Stock.

The  $1,875,000  in  proceeds  from  the financing transaction  were
allocated to the debt features and to  the warrants based upon their
fair values. After the latter allocations,  there  was  $170,061  of
remaining  value  to  be  allocated  to  the  Note  on the financial
statements.

The  debt  discount  is being accreted using the effective  interest
method over the term of the note.

The value of the discount  on  the  converted  notes on the books is
being  accreted  over the term of the note (three  years).  For  the
years ended December 31, 2004 and 2003, the Company accreted $52,300
and $0, respectively, of debt discount related to the Notes. For the
three months ended  March 31, 2005, the  Company  accreted  $155,101
of the debt discount related to these Notes.

WARRANTS ISSUED

The estimated fair value  of  the  3,125,000  warrants  at  issuance
(11/11/2004)  was  $936,714  and has been classified as a derivative
instrument  and recorded as a liability  on  the  Company's  balance
sheet  in  accordance   with  current  authoritative  guidance.  The
estimated fair value of the warrants was determined using the Black-
Scholes option-pricing model  with  a  closing  price  of  $0.40, an
exercise price of $0.30, a 5.0 year term, and a volatility factor of
89%. The model uses several assumptions including: historical  stock
price  volatility  (utilizing  a  rolling 120 day period), risk-free
interest rate (3.50%), remaining maturity,  and the closing price of
the Company's common stock to determine estimated  fair value of the
derivative liability. In valuing the warrants at December  31, 2004,
the  company used the closing price of $0.65, the exercise price  of
$0.30,  a  4.88  year  remaining  term,  and a volatility of 116% In
accordance  with  the  provisions of SFAS No.  133,  Accounting  for
Derivative Instruments,  the  Company  is  required  to  adjust  the
carrying  value  of the instrument to its fair value at each balance
sheet date and recognize  any  change  since the prior balance sheet
date  as  a  component  of  Other  Income  (Expense).   The  warrant
derivative liability at December 31, 2004, had increased  to  a fair
value  of $1,785,877, due in part to an increase in the market value
of the Company's common stock to $0.65 from $0.40 at issuance, which
resulted  in  an  "other  expense" item of $849,163 on the Company's
books.  For  the  three  months  ended  March 31,  2005, the warrant
derivative  liability had decreased to a value of $856,190,  due  in
part to a decrease in the market value of the Company's common stock
to $0.50 from  $0.65  at  December  31,  2004,  which resulted in an
"other  income"  item   of  $929,687  for  the  three  months  ended
March 31,  2005. The  company  used a closing  price  of  $0.50,  an
exercise price  of  $0.30,  a  4.63  years remaining term, and a 37%
volatility factor.

The  recorded  value  of such warrants can  fluctuate  significantly
based  on  fluctuations  in  the  market  value  of  the  underlying
securities  of  the issuer of  the  warrants,  as  well  as  in  the
volatility of the  stock  price during the term used for observation
and the term remaining for the warrants.

In accordance with Statement  of  Financial Accounting Standards No.
133, "Accounting for Derivative Instruments and Hedging Activities,"
as amended ("SFAS 133"), the debt features  provision (collectively,
the features) contained in the terms governing  the  Notes  are  not
clearly  and  closely  related  to the characteristics of the Notes.
Accordingly,   the  features  qualified   as   embedded   derivative
instruments at issuance  and,  because  they  do not qualify for any
scope exception within SFAS 133, they were required  by  SFAS 133 to
be accounted for separately from the debt instrument and recorded as
derivative financial instruments.

DEBT FEATURES

Pursuant  to the terms of the Notes, these notes are convertible  at
the option of the holder, at anytime on or prior to maturity.  There
is an additional  interest  rate  adjustment  feature,  a liquidated
damages  clause,  a  cash  premium option, as well as the redemption
option.  The debt features represents an embedded derivative that is
required to be accounted for  apart  from  the underlying Notes.  At
issuance  of  the  Notes  (11/11/2004),  the debt  features  had  an
estimated initial fair value of $768,225,  which  was  recorded as a
discount to the Notes and a derivative liability on the consolidated
balance  sheet. In subsequent periods, if the price of the  security
changes, the embedded derivative financial instrument related to the
debt  features   will  be  adjusted  to  the  fair  value  with  the
corresponding charge  or  credit  to  other  expense or income.  The
estimated fair value of the debt features was  determined  using the
probability  weighted  averaged expected cash flows / Lattice  Model
with a closing price of  $0.40,  an  exercise  price of $0.30, a 3.0
year  term, and a volatility factor of 89%. The model  uses  several
assumptions  including: historical stock price volatility (utilizing
a  rolling  120   day  period),  risk-free  interest  rate  (3.50%),
remaining maturity,  and  the  closing price of the Company's common
stock to determine estimated fair value of the derivative liability.
In valuing the debt features at  December 31, 2004, the company used
the closing price of $0.65 and the  exercise  price  of  $0.30, 2.88
year  remaining  term, and a volatility of 116%. For the year  ended
December 31, 2004, due in part to an increase in the market value of
the Company's common  stock  to  $0.65  from  $0.40 at issuance, the
Company recorded an "other expense" on the consolidated statement of
operations  for  the change in fair value of the  debt  features  of
approximately $1,639,953.  At  December 31, 2004, the estimated fair
value  of the debt features was approximately  $2,408,178.  For  the
three  months  ended  March  31,  2005, the estimated value  of  the
debt features decreased to $1,593,734, thus the  company recorded an
"other income" item on the consolidated statement  of operations for
the change in fair value of the debt features related to these notes
of  $814,444  for  the   three   months  ended  March 31, 2005.  The
company used a closing  price of $0.50, an exercise  price of  $0.30,
a 2.63 years remaining term, and a 37% volatility factor.

The recorded value of the  debt  features  related  to the Notes can
fluctuate significantly based on fluctuations in the  fair  value of
the  Company's  common  stock,  as  well as in the volatility of the
stock  price  during  the term used for  observation  and  the  term
remaining for the warrants.

Pursuant to the terms of  the  Notes,  the Company has the option of
prepaying the outstanding Principal Amount  in  whole or in part, by
paying  to  the  Holder a sum of money equal to one  hundred  twenty
percent (120%) of the Principal Amount to be redeemed, together with
accrued but unpaid interest thereon and any and all other sums due.

Because  the  terms  of  the  2004  convertible  note  require  such
classification, the accounting rules required additional convertible
notes  and  non-employee   warrants   to   also   be  classified  as
liabilities,  regardless  of  the terms of the new notes  and  /  or
warrants.  This presumption has  been  made  due  to  the company no
longer having the control to physical or net share settle subsequent
convertible  instruments because it is tainted by the terms  of  the
2004 convertible notes.  Were the 2004 convertible notes to not have
contained those  terms  or  even  if  the  2004 transaction were not
entered into, it could have altered the treatment  of  the March 31,
2005  notes and the conversion features of the latter agreement  may
have resulted in a different accounting treatment from the liability
classification.  The  March 31, 2005 note, as well as any subsequent
convertible  notes  or  warrants,  will  be  treated  as  derivative
liabilities until all such provisions are settled.

NOTES PAYABLE - $125,000, MARCH 2005

In March 2005, the Company  issued  $125,000  in principal amount of
Notes  to third parties. As part of the financing  transaction,  the
Company  issued  warrants to purchase 300,000 shares of common stock
at a per share purchase price of $0.50 per share. The Warrants shall
be exercisable until  five  (5)  years  after  the Issue Date of the
Warrants.

The Notes accrue interest at a rate 12% per annum. The Notes are due
and payable in March 2007.  After a thorough review  of the terms of
the  note  and respective covenants, the company has determined  the
more conservative  method  of including the entire debt as a current
liability on the balance sheet.

Interest shall be calculated  on  the  basis  of  a  360  day  year.
Interest  on  the  Principal  Amount  shall  be  payable monthly, in
arrears, commencing the first day of the month after  120  days from
the closing and on the first day of each consecutive calendar  month
thereafter  (each,  a  "Repayment  Date")  and on the Maturity Date,
whether by acceleration or otherwise.

Redemption Option - The Company will have the  option  of  prepaying
the  outstanding Principal Amount ("Optional Redemption"), in  whole
or in  part,  by  paying  to  the Holder a sum of money equal to one
hundred  twenty  percent  (120%)  of  the  Principal  Amount  to  be
redeemed, together with accrued but unpaid interest thereon

Holder's Conversion Rights. The Holder shall have the right, but not
the obligation, to convert all or any  portion of the then aggregate
outstanding Principal Amount of this Note,  together  with  interest
and fees due hereon, into shares of Common Stock.

The  $125,000  in  proceeds  from  the  financing  transaction  were
allocated  to the conversion option, call option and to the warrants
based upon their  fair  values.  After  the  latter allocations, the
company allocated $58,667 to the carrying value  of  the  debt. That
debt discount is being accreted using the effective interest  method
over the term of the note.

The  value  of  the  discount on the converted notes on the books is
being accreted over the term of the note (three years).For the three
months ended  March  31,  2005,  the  Company  accreted  $0  of  the
debt discount related to these Notes.

WARRANTS ISSUED

The  estimated  fair value  of  the  300,000  warrants  at  issuance
(3/31/2005) was $56,785  and  has  been  classified  as a derivative
instrument  and  recorded  as  a liability on the Company's  balance
sheet  in  accordance  with  current   authoritative  guidance.  The
estimated fair value of the warrants was determined using the Black-
Scholes  option-pricing model. The model  uses  several  assumptions
including:  historical  stock  price volatility (utilizing a rolling
120  day  period),  risk-free  interest   rate   (3.50%),  remaining
maturity,  and  the closing price of the Company's common  stock  to
determine estimated  fair  value  of  the  derivative  liability. In
valuing the warrants at March 31, 2005, the company used the closing
price  of $0.50, the exercise price of $0.50, a 5 year term,  and  a
37% volatility factor. In accordance with the provisions of SFAS No.
133, Accounting  for Derivative Instruments, the Company is required
to adjust the carrying  value of the instrument to its fair value at
each balance sheet date and  recognize  any  change  since the prior
balance sheet date as a component of Other Income (Expense). For the
three  months  ended  March  31, 2005,  the  warrant  liability  had
not changed as it was the same as the date of issuance.

The  recorded value of such  warrants  can  fluctuate  significantly
based  on  fluctuations  in  the  market  value  of  the  underlying
securities  of  the  issuer  of  the  warrants,  as  well  as in the
volatility  of  the stock price during the term used for observation
and the term remaining for the warrants.

In accordance with  Statement  of Financial Accounting Standards No.
133, "Accounting for Derivative Instruments and Hedging Activities,"
as amended ("SFAS 133"), the holder's  conversion  right  provision,
interest rate adjustment provision, liquidated damages clause,  cash
premium  option,  and  the redemption option (collectively, the debt
features) contained in the terms governing the Notes are not clearly
and  closely  related  to  the   characteristics   of   the   Notes.
Accordingly,  the  debt  features  qualified  as embedded derivative
instruments  at issuance and, because they do not  qualify  for  any
scope exception  within  SFAS 133, they were required by SFAS 133 to
be accounted for separately from the debt instrument and recorded as
derivative financial instruments.

DEBT FEATURES

Pursuant to the terms of the  Notes,  these notes are convertible at
the option of the holder, at anytime on or prior to maturity.  There
is  an  additional interest rate adjustment  feature,  a  liquidated
damages clause,  a  cash  premium option, and the redemption option.
The debt features represents an embedded derivative that is required
to be accounted for apart from the underlying Notes.  At issuance of
the Notes (3/31/05), the debt features had an estimated initial fair
value of $9,548, which was recorded as a discount to the Notes and a
derivative  liability  on  the   consolidated   balance   sheet.  In
subsequent  periods,  if  the  price  of  the  security changes, the
embedded  derivative  financial  instrument  related   to  the  debt
features  will  be  adjusted  to  fair  value with the corresponding
charge  or credit to other expense or income.   The  estimated  fair
value of  the  debt  features  was  determined using the probability
weighted averaged expected cash flows  /  Lattice  Model.  The model
uses   several   assumptions   including:   historical  stock  price
volatility (utilizing a rolling 120 day period),  risk-free interest
rate  (3.50%),  remaining  maturity,  and the closing price  of  the
Company's  common stock to determine estimated  fair  value  of  the
derivative liability.  In  valuing  the  debt  features at March 31,
2005,  the  company  used the closing price of $0.50,  the  exercise
price of $0.50, a 2.0  year  term,  and a 37% volatility factor. For
the three  months  ended  March  31, 2005,  the  estimated  value of
the debt features had not changed as it was the same as the date  of
issuance.

The recorded value of the debt features  related  to  the  Notes can
fluctuate  significantly based on fluctuations in the fair value  of
the Company's  common  stock,  as  well  as in the volatility of the
stock  price  during  the  term used for observation  and  the  term
remaining for the warrants.

The  significant fluctuations  can  create  significant  income  and
expense items on the financial statements of the company.

For the three  months  ended  March  31, 2005, we  recorded an other
income  item  of $1,744,131,  of  which  $814,444  of  other  income
related  to the decrease in value of the debt features on the $1.875
million convertible  note, $929,687 of  other income  related to the
decrease in warrant liability  related  to  the  warrants granted in
November  2004  to  the  holder's of the $1.875 million  convertible
note, $0  of  other  income  item related warrants  granted  to  the
holders of the March 2005 $125,000 convertible note, and finally  $0
of other expense related to the derivative  liability related to the
debt features of the March 2005 $125,000 convertible note. A tabular
reconciliation of this adjustment follows:

For the three months ended March 31, 2005:

  $  814,444 income, decrease in value of 2004 derivative liability
     929,687 income, decrease in value of 2004 warrant liability
           - expense, increase in 2005 derivative liability
           - income, decrease in value of 2005 warrant liability
   ----------
  $1,744,131 other income related to convertible debt


For the  three months  ended  March  31 , 2005, the company recorded
$155,101  of interest expense  related  to  the  accretion  of  debt
related to the convertible financing.

For the three months ended March 31, 2005:

     $155,101  of  interest  expense  related  to  accretion of 2004
	       convertible debt
            -  of interest expense related  to accretion of 2005
	       convertible debt
     --------
     $155,101  of interest expense related to convertible debt


The balance of the carrying  value  of  the  convertible  debt as of
March 31, 2005 is:


$  222,361  December 31, 2004 value
   155,101  accretion of 2004 convertible debt
    58,667  original carrying value on 2005 convertible debt
         -  accretion of 2005 convertible debt
    63,275  interest accrual on loan minus payments of interest
  --------
$  499,404  March 31, 2005 carrying value of debt


The balance of the carrying value of the derivative liability  as of
March 31, 2005 is:


$2,408,178  December 31, 2004 value of derivative liability
  (814,444) income, decrease in value of 2004 derivative liability
     9,548  original carrying value on 2005 derivative liability
         -  expense, increase in 2005 derivative liability
-----------
$1,603,282  March 31, 2005 value of derivative liability


The  balance  of  the  carrying value of the warrant liability as of
March 31, 2005 is:


$ 1,785,877  December 31, 2004 value of warrant liability
   (929,687) income, decrease in value of 2004 warrant liability
     56,785  original carrying value on 2005 warrant liability
         -   income, decrease in 2005 warrant liability
-----------
$   912,975  March 31, 2005 value of warrant liability


NOTE 5- RECEIVABLE FROM NUTEK OIL - ASSET HELD FOR SALE

On April 14, 2005, DSEN filed a Current Report on Form 8-K, relating
to the conversion of the South Texas Oil Company asset held for sale
into shares in South Texas Oil Company (formerly known as Nutek Oil)
and will be distributing  its  ownership interest in South Texas Oil
Company to shareholders of DSEN.

The  dividend  will  take  the  form   of   a  dividend  certificate
representing restricted common stock, which will  be  distributed to
DSEN's  beneficial stockholders of record as of the record  date  of
April 27, 2005.

					F-5
<PAGE>

The stock  dividend  will  be distributed to owners of DSEN's common
stock as of the record date  in  a ratio of one share of South Texas
Oil Company, for approximately every  18 shares of common stock held
in DSEN.

On December 31, 2004 the company reviewed any need for impairment of
assets per SFAS 144. A loan is considered impaired if it is probable
that the creditor will be unable to collect  all  amounts  due under
the  contractual  terms  of  the  loan  agreement. In evaluating the
impairment of the assets of the company at  year  end,  the  company
considered,  among  other  items,  (1) materiality of the asset, (2)
previous  loss  experience,  and (3) assets  that  are  not  readily
marketable or susceptible to decline in value.

After discussions with the Board  and  with  the  management of both
Datascension,  and Nutek Oil, it was determined to be  in  the  best
interest  of the  Company  and  shareholders  for  the  note  to  be
converted to stock and distributed to the shareholders.

Pursuant to  the previous dividends on August 1, 2001 and January 8,
2004, the company  determined  it  was  in the best interest of it's
shareholders  to convert the balance of the  note  into  the  common
stock of Nutek  Oil  and  distribute  the  pro  rata  shares  to our
shareholders. This coincides with managements plan to write off  any
assets  which  are  attributable to the history of the company which
are non-operational in nature, etc.

As of the December 31,  2004,  the value of the loan to be converted
is $1,015,014 and is classified  on the balance sheet of the Company
as an Asset Held For Sale.

The stock of Nutek Oil traded over  $1.00  during  the  week  of the
conversion  to  settle  the debt owed to Datascension. The stock has
since traded as high as $1.25.  Management  felt  strongly  that the
shareholders  and company were never at risk of losing the value  of
the receivable.  When Datascension made the agreement to convert the
receivable into the  stock  of  Nutek  Oil,  it  was  agreed  to  be
converted  at  the  $1,015,014  value of stock. The number of shares
(957,349) was only later determined  based on the then average price
of $1.06. Management did not feel there  was  a risk of shareholders
receiving less than full credit for the value of the note.

NOTE 6 - STOCKHOLDERS' EQUITY

      During  the  three  months ended March 31, 2005, DSEN  issued  securities
using the exceptions available  under  the  Securities  Act  of  1933 including
unregistered sales made pursuant to Section 4(2) of the Securities  Act of 1933
as follows:

      On  March  31, 2005, 500,000 shares of restricted common stock valued  at
$.50 per share were  issued  pursuant  to  a consulting agreement in connection
with which we are to receive certain investor  relations  services.  The shares
have been issued for a two year contract which can be cancelled after the first
year and 50% of the shares returned. The issuance of these  securities was in a
transaction  deemed  to be exempt under Section 4(2) of the Securities  Act  of
1933 as a sale of securities  not  involving  a  public  offering.  We  made  a
determination  that  the  consultant  was a sophisticated investors with enough
knowledge and experience in business to  evaluate  the  risks and merits of the
investment.

      On March 31, 2005, 300,000 shares of restricted common  stock  valued  at
$.50  per  share  were  issued pursuant to a consulting agreement in connection
with which we are to receive  certain  investor relations services.  The shares
have been issued for a two year contract which can be cancelled after the first
year and 50% of the shares returned. The  issuance of these securities was in a
transaction deemed to be exempt under Section  4(2)  of  the  Securities Act of
1933  as  a  sale  of  securities  not involving a public offering. We  made  a
determination that the consultant was  a  sophisticated  investors  with enough
knowledge  and experience in business to evaluate the risks and merits  of  the
investment.

      On March 31, 2005, DSEN issued a $125,000 Convertible Debenture, pursuant
to a Securities  Purchase  Agreement (the "Agreement") to the Longview Fund LP.
In addition, DSEN issued a common  stock  purchase  warrant to purchase 300,000
post  reverse  shares of DSEN common stock at an exercise  price  of  $.50  per
share. The issuance  of  these  securities  was  in  a transaction deemed to be
exempt under Section 4(2) of the Securities Act of 1933 as a sale of securities
not involving a public offering.  We made a determination  that  the  investors
were  sophisticated  investors with enough knowledge and experience in business
to evaluate the risks  and  merits  of  the  investment  as  well as accredited
investors.

					F-6
<PAGE>
      On  March  31, 2005, 50,000 shares of restricted common stock  valued  at
$.50 per share were  issued  pursuant  to  a consulting agreement in connection
with which we are to receive certain investor  relations services. The issuance
of these securities was in a transaction deemed to be exempt under Section 4(2)
of the Securities Act of 1933 as a sale of securities  not  involving  a public
offering.  We  made  a  determination  that  the consultant was a sophisticated
investors with enough knowledge and experience  in  business  to  evaluate  the
risks and merits of the investment.

      On  March  31,  2005, 100,000 shares of restricted common stock valued at
$.50 per share were issued  pursuant  to  an  employee  in  connection with his
employment agreement which offered the executive a 100,000 share signing bonus.
The issuance of these securities was in a transaction deemed to be exempt under
Section  4(2)  of  the  Securities  Act  of  1933  as a sale of securities  not
involving a public offering. We made a determination  that the consultant was a
sophisticated  investors with enough knowledge and experience  in  business  to
evaluate the risks and merits of the investment.

      All of these  transactions were exempt from the registration requirements
of the Securities Act of 1933, as amended, by virtue of the exemptions provided
under section 4(2) was available because:

 -   The  transfer  or issuance  did  not  involve  underwriters,  underwriting
    discounts or commissions;
 -  The  shares were purchased  for  investment  purposes  without  a  view  to
    distribution;
 -  A restriction on transfer legend was placed on all certificates issued;
 -  The distributions did not involve general solicitation or advertising; and,
 -  The distributions  were  made  only  to  insiders,  accredited investors or
    investors  who  were  sophisticated  enough to evaluate the  risks  of  the
    investment.  Each

    shareholder was given access to all information  about our business and the
    opportunity to ask questions and receive answers about  our  business  from
    our management prior to making any investment decision.


NOTE 7 - RELATED PARTY TRANSACTIONS

As of March 31, 2005, the Company has  an  outstanding  note  payable  to Scott
Kincer,  the  Company's  COO,  in  the amount of $23,000.  This payable accrues
interest at 1% monthly due on the first day of each month.

					F-7
<PAGE>

NOTE 8 - SUBSEQUENT EVENTS

Effective April 1, 2005, Scott Kincer, the  Company's  current  Chief Operating
Officer  was  appointed  the  Chief Executive  Officer  and  Chairman  of   the
Board.  It is not anticipated that  Mr.  Kincer's  employment  contract will be
altered or materially affected with this change.

As of April 1, 2005, the Company's corporate head  office are located at 145 S.
State  College Blvd, Suite 350, Brea CA 92821.  The new  company  phone  number
will  be  714-482-9750  and  714-482-9751  (fax).   This  address  and  contact
information   is  the  current  location  for  the  Datascension  International
California office.


NOTE 9 - FOREIGN OPERATIONS

The company currently  operates  out  of  the United States, Costa Rica and the
Dominican Republic.  The future plans of the company involve the slowing growth
at  the  Dominican  Republic  facility  while focusing  on  the  potential  and
available growth in Costa Rica.  Management  does  not feel there is a currency
risk  or  need  to assess a foreign currency translation  adjustment  or  other
comprehensive income  item as income and expense items are negotiated in the US
dollar.  The Company maintains  their  accountings  records in U.S. dollars and
all payments are made in US dollars.  All debts and assets  on the books of the
company are valued based on US dollars and are not translated  from  a  foreign
currency amount.  The Company currently coordinates all foreign operations, and
supervision  activities  using  part  time  employees, consultants and contract
labor.  Approximately 85% of the company's workforce  is  outside of the United
States.  Currently 100% of the company's clients are US based  companies.   Any
resulting foreign exchange fluctuations do not affect the payment of employees,
contract labor or off shore operations.

NOTE 10 - RESTATEMENT OF FINANCIAL STATEMENTS

2003:

The net loss for 2003 was previously reported  as  $(182,895), while
the 2003 restated loss is $246,533, an increase of $63,638, which is
attributable to the increase in amortization expense of $63,638. The
effect of the restatement to the 2003 balance sheet  was  a decrease
in the asset value of the intangible assets which had previously not
been  amortized  correctly.  The value of the other assets decreased
$63,638.

2004:

The  loss  after discontinued operations  for  2004  was  originally
$4,791,105,   while   the  2004  restated  loss  after  discontinued
operations is reported  as  $6,052,366,  an  increase of $1,261,261.
This  is  due  to  an  increase  in  other expenses related  to  the
convertible  debt  of $2,489,116, as well  as  an  increase  in  the
interest expense related to the convertible debt of $52,300, coupled
with a decrease in the  beneficial  conversion feature debt discount
expense  of $1,203,646, a decrease in  the  loss  from  discontinued
operations  of  $63,638,  and  a  decrease  in  interest  expense of
$12,871.

On  the 2004 balance sheet, the restatement resulted in the  removal
of $2,077,604  of  debt  discount  from  the other asset section, an
increase in prepaid expenses of $5,879. The  convertible debt in the
liability  section  of the company's financial statements  decreased
from $1,893,750 to $241,111,  while  there  was  an  increase in the
derivative liability from $0 to $2,408,178, as well as  an  increase
in  the  warrant  liability from $0 to $1,785,877 and a decrease  in
additional paid in capital of $3,300,000.

The basic loss per  share  increased  from  the  previously reported
$0.19 per share to $0.28 per share for the year ended  December  31,
2004, while the diluted loss per share increased from the previously
reported $0.18 per share to $0.26 per share.


2005:

The  net  loss for  the  three  months  ended  March 31,  2005,  was
originally $(408,048), while  the  three months ended March 31, 2005
restated income is reported as $1,402,311,an increase of $1,810,359.
This  is  due  to  an  increase  in  other  income  related  to  the
convertible debt of $1,744,131,as well as a decrease in the interest
expense  related to the convertible  debt  of  $27,191,  a  decrease
in interest expense of $39,640 and an increase in general and  admin
expenses of $603.

On  the  March 31,  2005  balance sheet,  the  restatement  resulted
from an increase in prepaid expenses  of  $33,158.  The  convertible
debt  in the liability section of the company's financial statements
increased  $374,404, an  increase  in  the  derivative liability  of
$1,603,282, and the warrant liability increased $912,975.

The  basic  income per share increased from the previously  reported
$(0.03) per share  to  $0.09  per  share  for the three months ended
March  31,  2005,  while  the diluted  income  per  share  increased
from the previously reported $(0.03) per share to $0.09 per share.





					F-8
<PAGE>

Item 2. Management's Discussion and Analysis of Financial Condition and Results
of Operations.

      The following is a discussion of certain factors affecting DSEN's results
of operations, liquidity and capital resources. You  should  read the following
discussion  and  analysis  in  conjunction  with  the Registrant's consolidated
financial statements and related notes that are included  herein  under  Item 1
above.

Overview

      Datascension  Inc,  ("DSEN")  through  its  sole  subsidiary Datascension
International,  Inc,  is  engaged  in data gathering and conducting  outsourced
market research. Its expertise is in the collection, storage, and processing of
data.  Datascension International's  management  team  has  over  30  years  of
experience  in working with clients to gather the information they need to make
changes  or  advancements  to  their  operations.   Datascension  International
services a variety  of  industries  and  customers  (including the hospitality,
entertainment, and automotive sectors) with emphasis and commitment to customer
service, quality assurance and on-time project management.

Critical Accounting Policies and Estimates

      Our  discussion  and  analysis  of  financial condition  and  results  of
operations is based upon our financial statements,  which have been prepared in
accordance with accounting principles generally accepted  in  the United States
of America. The preparation of these financial statements requires  us  to make
estimates   and   judgments   that  affect  the  reported  amounts  of  assets,
liabilities, revenue and expenses,  and related disclosure of contingent assets
and liabilities. On an ongoing basis,  we  evaluate  our estimates. We base our
estimates  on historical experience and on various other  assumptions  that  we
believe  to  be   reasonable  under  the  circumstances.  These  estimates  and
assumptions provide  a  basis for making judgments about the carrying values of
assets and liabilities that are not readily apparent from other sources. Actual
results  may  differ  from  these  estimates  under  different  assumptions  or
conditions, and these differences may be material.

      We believe the following  critical  accounting  policies  affect its more
significant judgments and estimates used in the preparation of its consolidated
financial statements.

Foreign Currency

      DSEN  maintains  its accounting records in U.S. dollars and all  payments
are made in US dollars.   Any  resulting  foreign  exchange fluctuations do not
affect the payment of employees, contract labor or off shore operations.

   Datascension interacts with Costa Rica and the Dominican Republic
in two ways; 1) leasing of property,  and  2)  leasing  of  workers.
Datascension   pays   companies  incorporated  in  their  respective
counties for their services. Datascension directs the workers on how
to perform their job; the  worker  leasing company takes care of all
government reporting that may be required.  Therefore  there  are no
government  regulations  that  affect  our operations and we are not
aware  of  any  government  regulations,  if   any,  that  would  be
applicable  to those entities that we do business  with  that  would
affect us.

Revenue Recognition.

      We  recognize revenues when survey data is delivered  to  the  client  in
accordance  with  the  terms of our agreements. Research products are delivered
within a short period, generally ranging from a few days to approximately eight
weeks. An appropriate deferral is made for direct costs related to contracts in
process, and no revenue  is  recognized  until  delivery  of the data has taken
place.  Billings rendered in advance of services being performed,  as  well  as
customer  deposits  received  in  advance,  are recorded as a current liability
included in deferred revenue. We are required  to  estimate contract losses, if
any,  and  provide  for  such  losses  in the period they  are  determined  and
estimable.  We do not believe that there  are  realistic  alternatives  to  our
revenue recognition  policy  given the short period of service delivery and the
requirement to deliver completed surveys to our
                                          5

<PAGE>

customers. We do not believe there  is  significant risk of recognizing revenue
prematurely since our contracts are standardized, the earnings process is short
and no single project accounts for a significant portion of our revenue.

Intangible Assets

The Company has adopted SFAS No. 142, "Goodwill and Other Intangible
Assets", which requires  that goodwill and  other  indefinite  lived
intangible assets are no  longer  amortized,  but reviewed annually,
or sooner  if  deemed necessary,  for  impairment.   Under  guidance
from  SFAS  No.  142, management has  determined that the  assets in
the company determined  to  be  discontinued  operations  should  be
impaired.  The respective assets have been written down. See Note 13
Discontinued Operations.

Convertible Debt Financing and Derivative Liabilities

In accordance with Statement of Financial  Accounting  Standards No.
133, "Accounting for Derivative Instruments and Hedging Activities,"
as amended ("SFAS 133"), the company has reviewed the terms  of  its
existing  convertible  debt  financing  and  the holder's conversion
right provision (collectively, the features) contained  in the terms
governing  the  Notes  are  not  clearly and closely related to  the
characteristics of the Notes.  Accordingly,  the  features qualified
as embedded derivative instruments at issuance and,  because they do
not  qualify  for  any  scope  exception within SFAS 133, they  were
required by SFAS 133 to be accounted  for  separately  from the debt
instrument   and   recorded  as  derivative  financial  instruments.
Because  the  terms  of  the  2004  convertible  note  require  such
classification, the accounting rules required additional convertible
notes  and  non-employee   warrants   to   also   be  classified  as
liabilities,  regardless  of  the terms of the new notes  and  /  or
warrants.  Were the 2004 convertible  notes  to  not  have contained
those  terms or even if the 2004 transaction were not entered  into,
it could  have altered the treatment of the March 31, 2005 notes and
the conversion features of the latter agreement may have resulted in
a different  accounting treatment from the liability classification.
The March 31, 2005 note, as well as any subsequent convertible notes
or warrants, will  be  treated  as  derivative liabilities until all
such  provisions  are  settled.  (See  Convertible   Debt  Notes  to
Financial Statements for more information)

During  the  year ended December 31, 2004, we recorded an  aggregate
other expense item of $2,489,116, of which, $1,639,953 (expense) and
$849,163 (expense)  related  to  the  debt  features  and  warrants,
respectively,  to reflect the change in fair value of the derivative
liability. During  the  year  ended  December 31, 2003, there was no
income or expense items related to convertible  debt  as  there  was
none outstanding.

For the three  months  ended  March  31, 2005, we  recorded an other
income  item  of $1,744,131,  of  which  $814,444  of  other  income
related  to the decrease in value of the debt features on the $1.875
million convertible  note, $929,687 of  other income  related to the
decrease in warrant liability  related  to  the  warrants granted in
November  2004  to  the  holder's of the $1.875 million  convertible
note, $0  of  other  income  item related warrants  granted  to  the
holders of the March 2005 $125,000 convertible note, and finally  $0
of other expense related to the derivative  liability related to the
debt features of the March 2005 $125,000 convertible note. A tabular
reconciliation of this adjustment follows:

For the three months ended March 31, 2005:

  $  814,444 income, decrease in value of 2004 derivative liability
     929,687 income, decrease in value of 2004 warrant liability
           - expense, increase in 2005 derivative liability
           - income, decrease in value of 2005 warrant liability
   ----------
  $1,744,131 other income related to convertible debt


For the  three months  ended  March  31 , 2005, the company recorded
$155,101  of interest expense  related  to  the  accretion  of  debt
related to the convertible financing.

For the three months ended March 31, 2005:

     $155,101  of  interest  expense  related  to  accretion of 2004
	       convertible debt
            -  of interest expense related  to accretion of 2005
	       convertible debt
     --------
     $155,101  of interest expense related to convertible debt

The  recorded  value of the debt features related to the  Notes  can
fluctuate significantly  based  on fluctuations in the fair value of
the Company's common stock, as well  as  in  the  volatility  of the
stock  price  during  the  term  used  for  observation and the term
remaining for the warrants.  Additional details  of  the convertible
notes are included in our notes to the financial statements.

Asset valuation.

On December 31, 2004 the company reviewed any need for impairment of
assets per SFAS 144. A loan is considered impaired if it is probable
that  the creditor will be unable to collect all amounts  due  under
the contractual  terms  of  the  loan  agreement.  In evaluating the
impairment  of  the assets of the company at year end,  the  company
considered, among  other  items,  (1)  materiality of the asset, (2)
previous  loss  experience,  and (3) assets  that  are  not  readily
marketable or susceptible to decline in value

After discussions with the Board  and  with  the  management of both
Datascension,  and Nutek Oil, it was determined to be  in  the  best
interest  of the  Company  and  shareholders  for  the  note  to  be
converted to stock and distributed to the shareholders.

Pursuant to  the previous dividends on August 1, 2001 and January 8,
2004, the company  determined  it  was  in the best interest of it's
shareholders  to convert the balance of the  note  into  the  common
stock of Nutek  Oil  and  distribute  the  pro  rata  shares  to our
shareholders. This coincides with managements plan to write off  any
assets  which  are  attributable to the history of the company which
are non-operational in nature, etc.

As of the December 31,  2004,  the value of the loan to be converted
was  $1,015,014 and was classified  on  the  balance  sheet  of  the
Company as an Asset Held For Sale.

The stock  of  Nutek  Oil  traded  over $1.00 during the week of the
conversion  to  settle  the debt owed to  Datascension.   Management
feels strongly that the shareholders  and company were never at risk
of losing the value of the receivable.   When  Datascension made the
agreement to convert the receivable into the stock  of Nutek Oil, it
was  agreed to be converted at the $1,015,014 value of  stock.   The
number of shares was only later determined based on the then average
price of $1.06.

Pursuant   to  the  company's  review  of  APB  29,  par.  25,  "the
determination  of  value  of  non-monetary  transactions  should  be
determined  by  referring  to  estimated  realizable  values in cash
transactions  of  the same or similar assets, quoted market  prices,
independent appraisals,  estimated fair values of assets or services
received in exchange, and  other  available  evidence."   Management
feels  the  valuation is correct due to the quoted market prices  at
the time of the  transaction  and  estimated  fair  value  of assets
received.  The note was derived upon the sale of assets to Nutek Oil
and  then  the  note  was  settled  by  common stock worth that same
amount.

A total of $1,015,014 worth of securities  is to be issued to settle
the debt.  Full credit for the value of $1,015,014 is to be received
as it is to be settled with an equity equivalent  to  the full value
of  the  note,  so  management  does  not feel there is any risk  to
shareholders or the company, nor was it  deemed  necessary for there
to be a need to impair the receivable.  The 5 day  average  was used
to  determine  the  price for the settlement of the note receivable,
this average was $1.06.   Since  the note was settled with stock and
the trading price of the stock was  over  $1.06,  the  company chose
$1.06  as the conversion amount to use, and thus the 957,349  shares
to be issued was based on that amount.

DSEN's website address is http://www.datascension.com.

Results of Operations

      Analysis of the quarter ended  March 31, 2005  compared  to  the  quarter
ended March 31, 2004.

For the three-months, ended March 31, 2005,  DSEN  has  generated $2,005,024 in
revenues  compared to $2,034,455 in revenues for the three-months  ended  March
31, 2004, for  a  decrease of $29,431.   The decrease in revenue is a result of
time spent by staff on training for upcoming contracts.

Cost of goods sold for  the  three-months  ended  March 31, 2005 was $1,599,936
compared to $1,702,318 for the three-months ended March  31, 2004 or a decrease
of  $102,382.  This decrease was a result of the predictive  dialers previously
installed which contributed to the reduced cost per revenue hour.

Total  general and administrative expenses increased to $480,196 for the three-
months ended  March 31, 2005 from $178,236 for the three-months ended March 31,
2004, a net increase  of  $301,960.   This  increase  relates  to the increased
management costs of $72,881, increased training costs for upcoming projects  of
$187,333, increase cost of insurance of $22,483, along  with  the  professional
fees  involved during the winding down of operations in our Nevada office.

Depreciation expense  for  the  three-months  ended  March 31, 2005 was $41,266
compared to $84,841 for the three-months ended March 31,  2004,  a  decrease of
$43,575.  The  decrease resulted from the disposal and write down of assets  in
the fourth quarter of 2004.

Interest expense  for  the  three-months  ended  March  31,  2005  was  $74,115
compared  to  $30,019 for the three-months ended March 31, 2004 an increase  of
$44,096.   This  increase   includes the  amortization of  the financing  costs
and additional  interest cost related  to  the purchase of  predictive  dialers
during the previous year.

Datascension  generated a net income of $1,402,311 for the three  months  ended
March 31, 2005, versus  net  income  of  $41,569  for the  same period in 2004.
The increase of $1,360,742 is a  result of the  increase  in  gross  profit  of
$73,539,   along   with   the increased general  and  administrative  costs  of
$301,960, coupled  with   minor decrease in  depreciation  of  $43,575  and  an
increase in costs  related  to  the  convertible  debt  of $1,744,131 and other
expenses of $198,543. For the three  months ended  March  31,  2005,  DSEN  has
increased  its working capital  position by a net  amount  of  $1,408,685  from
negative $3,874,229  as of  December  31, 2004  to  negative  $2,465,544  as of
March 31, 2005. This is due to a decrease in cash of $332,747  and  a  decrease
in prepaid expenses  of $21,477, an increase in accounts  receivable of $2,837,
while  there was  also a decrease in current  liabilities  of  $340,567  and  a
decrease in convertible debt, derivative and warrant liabilities of $1,419,505.

Other Significant Subsequent Events occurring after March 31, 2005:

      On May 3, 2005, DSEN filed a Current Report  on Form 8-K, relating to the
appointment of Mr. Robert Sandelman to the Board of Directors of DSEN.




                                       6
<PAGE>
Capital Resources and Liquidity

      On  March  31,  2005  DSEN  had  total assets of $4,714,021  compared  to
$7,799,530 on March 31, 2004, a decrease  of  $3,085,509.   The  reason for the
decrease in assets  is a result of the distribution of the assets held for sale
of $1,015,014,along with a decrease in current assets of$114,326 and a decrease
in deposits of $6,751.  DSEN had a total  stockholders' equity  of $(46,173) on
March 31, 2005 compared to  $6,199,739 on  March 31, 2004, a decrease in equity
of  $6,245,912,  which  is in  part due to  the increase in current liabilities
of $3,163,313 and an increase in accumulated deficit of $6,523,970,along with a
net change in stock subscriptions of $326,250 related to the stock for services
issued on March 31, 2005.

      All  assets  are  booked  at  historical  purchase price and there is  no
variance between book value and the purchase price.

      On March 31, 2005 DSEN had Property and Equipment of $961,120 compared to
$1,927,541 on March 31, 2004,or a decrease of $966,421 which is a result of the
purchase of predictive dialers for Datascension's call  center  operations  and
the write down of assets at year end.

      As  discussed  above  DSEN  intends  to  meet  its  financial  needs  for
operations  through  the  collection of accounts receivable  and  servicing  of
current contracts.

      DSEN's capital resources  are  comprised  primarily of private investors,
who are either existing contacts of the Registrant's  management or who come to
the  attention  of the Registrant through brokers, financial  institutions  and
other intermediaries.  The  Registrant's  access to capital is always dependent
upon general financial market conditions. The  Registrant's  capital  resources
are not anticipated to change materially in 2005.

      DSEN   has  financed  operations  through  the  collections  of  accounts
receivable, servicing  of  existing  contracts and the sale of common stock and
through financing from financial institutions.  In  order to sustain operations
in  the near term, it is anticipated that DSEN has sufficient  working  capital
due to  the fact that on November 17, 2004, we issued $1,875,000 in convertible
notes, receiving net proceeds of $1,657,500.

      DSEN's  future  capital  requirements  will  depend  on numerous factors,
including the profitability of our research projects and our ability to control
costs.  We  believe  that  our current assets will be sufficient  to  meet  our
operating expenses and capital  expenditures.  However,  we cannot predict when
and if any additional capital contributions may be needed  and  we  may need to
seek  one  or  more  substantial  new  investors.  New  investors  could  cause
substantial dilution to existing stockholders.

      There  can  be  no  assurances  that  DSEN  will be successful in raising
additional capital via debt or equity funding, or that  any  such transactions,
if  consummated,  will  be  on  terms  favorable  to  DSEN.  In the event  that
additional capital is not obtained from other sources,  it may become necessary
to alter development plans or otherwise abandon certain ventures.

      If  DSEN  needs  to  raise additional funds in order to  fund  expansion,
develop new or enhanced services or products, respond to competitive  pressures
or acquire complementary products,  businesses  or technologies, any additional
funds raised through the issuance of equity or convertible debt securities, the
percentage ownership of the stockholders of DSEN  will be reduced, stockholders
may  experience  additional  dilution  and  such securities  may  have  rights,
preferences or privileges senior to those of  DSEN's  Common  Stock.  DSEN does
not currently have any contractual restrictions on its ability  to  incur  debt
and,  accordingly,  DSEN  could  incur  significant  amounts of indebtedness to
finance its operations.  Any such indebtedness could contain  covenants,  which
would restrict DSEN's operations.
                                          7
<PAGE>

Off-Balance Sheet Arrangements.

      DSEN currently does not have any off-balance sheet arrangements.

Forward-Looking Information

      This  quarterly  report contains forward-looking statements. The forward-
looking statements include all statements that are not statements of historical
fact. The forward-looking  statements  are  often  identifiable by their use of
words  such  as  "may," "expect," "believe," "anticipate,"  "intend,"  "could,"
"estimate," or "continue," "Plans" or the negative or other variations of those
or comparable terms.  Our  actual  results  could  differ  materially  from the
anticipated  results described in the forward-looking statements. Factors  that
could affect our  results  include,  but are not limited to, those discussed in
Item  2,  "Management's  Discussion and Analysis  or  Plan  of  Operation"  and
included elsewhere in this  report.   DSEN  makes  no  commitment to update any
forward-looking  statement or to disclose any facts, events,  or  circumstances
after the date hereof  that  may  affect  the  accuracy  of any forward-looking
statement.

Item 3. Controls and Procedures.

      (a)  Our  Chief Executive Officer (CEO) and Principal  Financial  Officer
evaluated the effectiveness  of  our  disclosure  controls  and  procedures (as
defined  in  Rules  13a-15(e) and 15d-15(e) of the Securities Exchange  Act  of
1934, as amended) as  of  the  end  of the period covered by this report. Based
upon the evaluation, concluded that the  disclosure controls and procedures are
effective in ensuring all required information  relating to DSEN is included in
this quarterly report.

      We also maintain a system of internal control  over  financial  reporting
(as  defined  in  Rules 13a-15(f) and 15d-15(f)) designed to provide reasonable
assurance regarding  the reliability of financial reporting and the preparation
of financial statements  for  external  purposes  in accordance with accounting
principles generally accepted in the United States of America.

      (b)   Changes  in  internal  controls.   During our  most  recent  fiscal
quarter,  there  have been no changes in our internal  control  over  financial
reporting that occurred  that have materially affected or are reasonably likely
to materially affect our internal control over financial reporting.

The  company  has  restated  the  December 31,  2004  10KSB,  as  well  as  the
the March 31, 2005 10QSB, the June 30, 2005 10QSB, and  the September  30, 2005
10QSB to reflect an adjustment in the treatment of the convertible debt entered
into in November 2004. Management is of the opinion that while the restatements
were made to the  financial  statements, the  company still maintains effective
controls over its financial statements.This restatement is viewed as a one-time
error and is not reflective of the controls in place. The one time error in the
accounting treatment was due to a previous  interpretation  of accounting rules
which had subsequently changed.



                            PART II. OTHER INFORMATION

Item 1. Legal Proceedings.

      DSEN is not a party  to  any  pending  material  legal proceeding. To the
knowledge  of  management,  no federal, state or local governmental  agency  is
presently  contemplating any proceeding  against  DSEN.  To  the  knowledge  of
management,  no  director, executive officer or affiliate of DSEN, any owner of
record or beneficially  of  more  than  5%  of  DSEN's  common stock is a party
adverse to DSEN or has a material interest adverse to DSEN in any proceeding.

Item 2. Unregistered Sales of Equity Security and Use of Proceeds.

      During  the  three  months ended March 31, 2005, DSEN  issued  securities
using the exceptions available  under  the  Securities  Act  of  1933 including
unregistered sales made pursuant to Section 4(2) of the Securities  Act of 1933
as follows:

                                          8

<PAGE>
      On  March  31, 2005, 500,000 shares of restricted common stock valued  at
$.50 per share were  issued  pursuant  to  a consulting agreement in connection
with which we are to receive certain investor  relations  services.  The shares
have been issued for a two year contract which can be cancelled after the first
year and 50% of the shares returned. The issuance of these  securities was in a
transaction  deemed  to be exempt under Section 4(2) of the Securities  Act  of
1933 as a sale of securities  not  involving  a  public  offering.  We  made  a
determination  that  the  consultant  was a sophisticated investors with enough
knowledge and experience in business to  evaluate  the  risks and merits of the
investment.

      On March 31, 2005, 300,000 shares of restricted common  stock  valued  at
$.50  per  share  were  issued pursuant to a consulting agreement in connection
with which we are to receive  certain  investor relations services.  The shares
have been issued for a two year contract which can be cancelled after the first
year and 50% of the shares returned. The  issuance of these securities was in a
transaction deemed to be exempt under Section  4(2)  of  the  Securities Act of
1933  as  a  sale  of  securities  not involving a public offering. We  made  a
determination that the consultant was  a  sophisticated  investors  with enough
knowledge  and experience in business to evaluate the risks and merits  of  the
investment.

      On March 31, 2005, DSEN issued a $125,000 Convertible Debenture, pursuant
to a Securities  Purchase  Agreement (the "Agreement") to the Longview Fund LP.
In addition, DSEN issued a common  stock  purchase  warrant to purchase 300,000
post  reverse  shares of DSEN common stock at an exercise  price  of  $.50  per
share. The issuance  of  these  securities  was  in  a transaction deemed to be
exempt under Section 4(2) of the Securities Act of 1933 as a sale of securities
not involving a public offering.  We made a determination  that  the  investors
were  sophisticated  investors with enough knowledge and experience in business
to evaluate the risks  and  merits  of  the  investment  as  well as accredited
investors.

      On  March  31, 2005, 50,000 shares of restricted common stock  valued  at
$.50 per share were  issued  pursuant  to  a consulting agreement in connection
with which we are to receive certain investor  relations services. The issuance
of these securities was in a transaction deemed to be exempt under Section 4(2)
of the Securities Act of 1933 as a sale of securities  not  involving  a public
offering.  We  made  a  determination  that  the consultant was a sophisticated
investors with enough knowledge and experience  in  business  to  evaluate  the
risks and merits of the investment.

      On  March  31,  2005, 100,000 shares of restricted common stock valued at
$.50 per share were issued  pursuant  to  an  employee  in  connection with his
employment agreement which offered the executive a 100,000 share signing bonus.
The issuance of these securities was in a transaction deemed to be exempt under
Section  4(2)  of  the  Securities  Act  of  1933  as a sale of securities  not
involving a public offering. We made a determination  that the consultant was a
sophisticated  investors with enough knowledge and experience  in  business  to
evaluate the risks and merits of the investment.

      All of these  transactions were exempt from the registration requirements
of the Securities Act of 1933, as amended, by virtue of the exemptions provided
under section 4(2) was available because:

 -  The  transfer  or  issuance  did  not  involve  underwriters,  underwriting
    discounts or commissions;
 -  The  shares were purchased  for  investment  purposes  without  a  view  to
    distribution;
 -  A restriction on transfer legend was placed on all certificates issued;
 -  The distributions did not involve general solicitation or advertising; and,
 -  The distributions  were  made  only  to  insiders,  accredited investors or
    investors  who  were  sophisticated  enough to evaluate the  risks  of  the
    investment.  Each
                                       9
 <PAGE>
    shareholder was given access to all information  about our business and the
    opportunity to ask questions and receive answers about  our  business  from
    our management prior to making any investment decision.

Item 3.  Defaults Upon Senior Securities

      None.

Item 4.  Submission of Matters to a Vote of Security Holders

      None.

Item 5.  Other Information

      None.

Item 6.  Exhibits and Reports on Form 8-K

Exhibits

      (a)  Exhibit 31. Certifications  required  by Rule 13a-14(a) or Rule 15d-
14(a)


     31.1  Certification  of Chief Executive Officer  and  Principal  Financial
Officer pursuant to 18 U.S.C.ss.1850  as adopted pursuant to Section 302 of the
Sarbanes-Oxley Act of 2002.

      (b)  Exhibit 32. Certifications required  by  Rule 13a-14(b) or Rule 15d-
14(b) and section 906 of the Sarbanes-Oxley Act of 2002, 18 U.S.C. Section 1350

     32.1  Certification  of  Chief Executive Officer and  Principal  Financial
Officer pursuant to 18 U.S.C.ss.1850  as adopted pursuant to Section 906 of the
Sarbanes-Oxley Act of 2002.

Reports on Form 8-K

(a)   Report on Form 8-K filed January 6, 2005, item 9.01.

      On January 6, 2005, DSEN filed a  Current Report on Form 8-K, pursuant to
Regulation FD relating to a press release issued on January 6, 2005.

(b)   Report on Form 8-K filed March 3, 2005, item 8.01.

      On March 3, 2005, DSEN filed a Current  Report  on  Form 8-K, relating to
changes  to  the  Board  of  Directors  of Century Innovations, Inc.  a  former
subsidiary of DSEN.

(c)   Report on Form 8-K filed March 8, 2005, items 5.02, 8.01 and 9.01.

      On March 8, 2005, DSEN filed a Current  Report  on  Form 8-K, relating to
the resignation of DSEN's Chief Executive Officer and Chairman  of  the  Board,
Murray  Conradie  and  the  Chief  Financial  Officer,  Jason  Griffith.   DSEN
additionally  reported  that  Scott Kincer would be the Chief Executive Officer
and Chairman of the Board effective  April 1, 2005 including a change in DSEN's
corporate address to 145 S. State College  Blvd, Suite 350, Brea CA 92821.

      Pursuant to Regulation FD, the Current  Report referenced a press release
issued on March 3, 2005.

                                         10


<PAGE>
(d)   Report on Form 8-K filed April 14, 2005, items 8.01 and 9.01.

      On April 14, 2005, DSEN filed a Current Report  on  Form 8-K, relating to
the
conversion of the South Texas Oil Company asset held for sale  into  shares  in
South  Texas Oil Company (formerly known as Nutek Oil) and will be distributing
its ownership interest in South Texas Oil Company to shareholders of DSEN.

      The  dividend  will  take the form of a dividend certificate representing
restricted  common  stock, which  will  be  distributed  to  DSEN's  beneficial
stockholders of record as of the record date of April 27, 2005.

      The stock dividend  will  be distributed to owners of DSEN's common stock
as of the record date in a ratio  of  one share of South Texas Oil Company, for
approximately every 18 shares of common stock held in DSEN.

(e)   Report on Form 8-K filed April 15, 2005, items 8.01 and 9.01.

      On April 15, 2005, DSEN filed a Current  Report  on Form 8-K, pursuant to
Regulation FD relating to a press release issued on April 14, 2005.

(f)   Report on Form 8-K filed April 28, 2005, item 9.01.

      On April 28, 2005, DSEN filed a Current Report on  Form  8-K, pursuant to
Regulation FD relating to a press release issued on April 26, 2005.

(g)   Report on Form 8-K filed May 3, 2005, item 5.02.

      On May 3, 2005, DSEN filed a Current Report on Form 8-K, relating  to the
appointment of Mr. Robert Sandelman to the Board of Directors of DSEN.

SIGNATURES

      In  accordance  with  Section  13  or  15(d)  of  the  Exchange  Act, the
registrant  caused  this  report to be signed on its behalf by the undersigned,
thereunto duly authorized.

                                  Datascension, Inc.

                                  /s/ Scott Kincer
                                  ----------------------
                                  Scott Kincer
                                  President, Chairman and Director
                                  (Principal Executive Officer)

                                  /s/ Scott Kincer
                                  -------------------
                                  Scott Kincer
                                  (Principal Financial Officer)

                               Date: February 9, 2006

      Pursuant to the requirements of Section 12 of the Securities Exchange Act
of 1934, the registrant has  duly caused this report to be signed on its behalf
by the undersigned, thereunto duly authorized.

                                  /s/ Scott Kincer
                                  ----------------------
                                  Scott Kincer
                                  President, Chairman and Director
                                  (Principal Executive Officer)

                                      11

<PAGE>
                                  /s/ Scott Kincer
                                  -------------------
                                  Scott Kincer
                                  (Principal Financial Officer)

                               Date: February 9, 2006



















                                      12